Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00816751 · ClinicalTrials.gov registry record · NA
Paracervical Versus Intracervical Lidocaine
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT00816751: Completed NA study, sponsored by University of California, San Diego.
NCT00816751 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 89 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00816751, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
The aim of this study is to estimate the efficacy of intracervical versus paracervical block on pain experienced during first trimester suction curettage without the use of preoperative cervical ripening. Because of the theoretical improved reliability of stromal block, the investigators hypothesize that intracervical block would produce lower pain scores than paracervical block at the time of cervical dilation.
Primary Outcome
VAS on a scale of 1 to 10 with 1 being lowest pain and 10 highest amount of pain
Interventions
- PROCEDURE Paracervical block
- PROCEDURE Intracervical
- DRUG Buffered Lidocaine, vasopressin, sodium bicarbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-02 |
| Phase | NA |
What the finished NCT00816751 record still lists
NCT00816751 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which Paracervical block is the first listed.
NCT00816751 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00816751 about?
NCT00816751 is a clinical study titled "Paracervical Versus Intracervical Lidocaine". The aim of this study is to estimate the efficacy of intracervical versus paracervical block on pain experienced during first trimester suction curettage without the use of preoperative cervical ripening. Because of the theoretical improved reliability of stromal block, the investigators hypothesize...
What is the current status of trial NCT00816751?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2007-12. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00816751?
The interventions under investigation include: Paracervical block (PROCEDURE), Intracervical (PROCEDURE), Buffered Lidocaine, vasopressin, sodium bicarbonate (DRUG).
Who is sponsoring clinical trial NCT00816751?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00816751's enrollment target sits among peer trials
89 972nd of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia